$4.23
-0.04-0.94%
At close: -
$4.36
0.133.07%
After Hours: Feb 14, 9:29 AM EDT
Comments
Loading...
Exagen (NASDAQ:XGN) Stock Quotes, Forecast and News Summary
Exagen Stock (NASDAQ: XGN) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Exagen (XGN) stock?
You can purchase shares of Exagen (NASDAQ:XGN) through any online brokerage.
Who are Exagen (XGN) competitors?
Other companies in Exagen’s space includes: bluebird bio (NASDAQ:BLUE), Aligos Therapeutics (NASDAQ:ALGS), Armata Pharmaceuticals (AMEX:ARMP), Inovio Pharmaceuticals (NASDAQ:INO) and Vistagen Therapeutics (NASDAQ:VTGN).
What is the forecast, or price target, for Exagen (XGN) stock?
Exagen has a consensus price target of $9.25.
What is the current price for Exagen (XGN)?
The stock price for Exagen (NASDAQ: XGN) is $4.36 last updated February 14, 2025 at 9:29 AM EST.
Does Exagen (XGN) pay a dividend?
There are no upcoming dividends for Exagen.
When is Exagen (NASDAQ:XGN) reporting earnings?
Exagen’s Q1 earnings are confirmed for Monday, May 12, 2025.
Is Exagen (XGN) going to split?
There is no upcoming split for Exagen.
What sector and industry does Exagen (XGN) operate in?
Exagen is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.